Tesomet study in general obese people.
Latest Information Update: 17 Mar 2021
At a glance
- Drugs Metoprolol/tesofensine (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Saniona
- 17 Mar 2021 New trial record
- 08 Mar 2021 According to a Saniona media release, The agency (FDA) stated that robust data from these analyses (mentione the analysis) could be useful in determining the level of cardiovascular assessment needed in Phase 3. The agency also acknowledged the challenge of conducting 24-hour monitoring in HO patients and said the analyses could be conducted in a separate study in general obese people.